CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
0.0858
+0.0043 (5.28%)
At close: Oct 31, 2024, 4:00 PM
0.0800
-0.0058 (-6.76%)
After-hours: Oct 31, 2024, 7:28 PM EDT
CERO Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 |
Oct '24 Oct 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Market Capitalization | 13 | 69 | 236 | 223 |
Market Cap Growth | -93.90% | -70.89% | 6.05% | - |
Enterprise Value | 20 | 70 | 236 | - |
Last Close Price | 0.08 | 11.00 | 10.27 | 9.91 |
PE Ratio | - | -28.32 | -345.96 | - |
PB Ratio | -1.81 | -4.84 | -21.46 | -29.02 |
P/FCF Ratio | -0.68 | -45.10 | -216.09 | -186.24 |
P/OCF Ratio | -0.68 | -45.10 | -216.09 | -186.24 |
EV/EBIT Ratio | -1.53 | -23.86 | -81.06 | - |
EV/FCF Ratio | -1.80 | -45.93 | -215.63 | - |
Debt / Equity Ratio | -0.87 | -0.11 | -0.06 | - |
Debt / FCF Ratio | -0.32 | -1.02 | -0.60 | - |
Quick Ratio | 0.43 | 0.02 | 0.02 | 11.20 |
Current Ratio | 0.48 | 1.65 | 1.38 | 13.88 |
Return on Assets (ROA) | -45.28% | -7.20% | -1.63% | - |
Earnings Yield | -22.48% | -3.69% | -0.28% | -0.24% |
FCF Yield | -54.12% | -2.22% | -0.46% | -0.54% |
Buyback Yield / Dilution | 41.71% | 70.97% | -133.12% | - |
Total Shareholder Return | 41.71% | 70.97% | -133.12% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.